Related Experiment Video
Updated: Jun 19, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
TOXIN AND ANTITOXIN OF AND PROTECTIVE INOCULATION AGAINST BACILLUS WELCHII
1Laboratories of The Rockefeller Institute for Medical Research.
This study reveals that Bacillus welchii produces a toxin causing red blood cell destruction and local tissue damage. An antitoxin was developed, demonstrating protective and curative effects against Bacillus welchii infections.
Area of Science:
- Bacteriology
- Immunology
- Pathology
Background:
- Bacillus welchii infections are a significant concern, particularly in wound settings.
- Understanding the pathogenic mechanisms of Bacillus welchii is crucial for developing effective treatments.
Purpose of the Study:
- To characterize the toxic properties of Bacillus welchii cultures.
- To investigate the potential for developing an antitoxin against Bacillus welchii toxins.
Main Methods:
- Comparative analysis of five Bacillus welchii cultures.
- In vivo studies in rabbits, guinea pigs, and pigeons to assess pathogenicity.
- In vitro assays to evaluate hemolytic and toxic effects of culture filtrates.
- Development and testing of antitoxin against Bacillus welchii toxin.
Main Results:
- Bacillus welchii infections primarily cause local tissue damage with limited systemic spread.
- Culture filtrates exhibit potent hemolytic and necrotizing activities, responsible for acute toxicity.
- A heat-labile toxin was identified, and an effective antitoxin was produced.
- Antitoxin demonstrated protective and curative properties against Bacillus welchii in animal models.
Conclusions:
- Bacillus welchii produces an exotoxin responsible for hemolytic and local tissue damage.
- The developed antitoxin shows promise for treating Bacillus welchii infections.
- Further research is needed to define the full therapeutic potential of the antitoxin.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Diphtheria
Botulism
Bacterial Toxins
Cross-reactivity
Tetanus
Vaccinations